Riskpilot← Back to searchSign inGet full accessCMM Treatment ApS
APSActiveCVR 38553038Mathildevej 12A, st. thActivities of holding companies · NACE 6421Est. 2017— employees
Revenue 2025
DKK -9K
+3% vs 2024
EBITDA margin
100.0%
-3% vs 2024
Equity ratio
—
Financial strength
Net profit 2025
DKK -9K
-3% vs 2024
| Revenue | DKK -9K | +3% |
| EBITDA | DKK -9K | -3% |
| Net profit | DKK -9K | -3% |
| Total assets | DKK 0 | -100% |
| Equity | DKK -6K | -306% |
| Employees | — | — |
Legal name
CMM Treatment ApS
CVR number
38553038
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
5. april 2017
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er ejerskab af andre selskaber, investeringer samt dermed beslægtet virksomhed.
Address
Mathildevej 12A, st. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -5 | -7 | -7 | -7 | -8 | -8 | -8 | -8 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -5 | -7 | -7 | -7 | -8 | -8 | -8 | -8 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -5 | -7 | -7 | -7 | -8 | -8 | -8 | -8 |
| Net financials | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 9 | -7 | -7 | -7 | -8 | -8 | -8 | -8 |
| Tax | -1 | -2 | -2 | -2 | -2 | 8 | -0 | -0 |
| Net profit | 10 | -6 | -6 | -6 | -6 | -16 | -8 | -8 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 36 | 30 | 24 | 18 | 32 | 16 | 8 | 0 |
| Equity | 30 | 25 | 19 | 13 | 27 | 11 | 3 | -6 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 6 |
| Total debt | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 6 |
EBITDA margin
-850000.0%
This company
15.8%
Market median
-5379847% vs market
20182025
Equity ratio
-572000.0%
This company
38.2%
Market median
-1497482% vs market
20182025
Return on equity
-850000.0%
This company
18.4%
Market median
-4619665% vs market
20182025
Net profit margin
-850000.0%
This company
8.1%
Market median
-10493927% vs market
20182025
Asset turnover
-8500.00×
This company
1.12×
Market median
-759029% vs market
20182025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20182025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-04-05 – 2018-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TF Management | Management | 2017 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25.0% | 25.0% | 2021 | |
| Individual | 25.0% | 25.0% | 2021 | |
| Individual | 25.0% | 25.0% | 2021 | |
TFJ ApS | Company | 25.0% | 25.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TFJ ApS
CMM Treatment ApS Board members of CMM Treatment ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Frilund Jacobsen | Management | 0 companies |